Medivation, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 01:00 PM
13 hrs ago | yahoo.com
Executives David T. Hung - Chief Executive Officer, President and Executive Director Analysts Matthew Roden - UBS Investment Bank, Research Division Matthew Roden - UBS Investment Bank, Research Division Good afternoon,...
Read more...
XTANDI patient pre-chemo ZYTIGA trial PREVAIL post-chemo Medivation prostate placebo indiscernible drug Casodex Lupron Astellas cancer survival